GGrantIndex
← Leaderboards

Kenneth Laurita

Case Western Reserve University

$7,509,909
Attributed
$11,006,612
Total exposure
9
Grants
7
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.6M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$11,006,612 · 9

By mechanism

R01$7,745,840 · 4
P01$1,044,473 · 1
RC1$972,594 · 1
R56$602,854 · 1
R21$435,875 · 1
R43$204,976 · 1

Top collaborators

Most similar at Case Western Reserve University

Same institution · by research overlap

Others in their field

Top investigators on “Arrhythmia

Research focus

ArrhythmiaHeartOpticsMapsAction PotentialsIn VivoElectrophysiology (Science)MyocardiumCardiacBasePropertyElectrocardiogramInnovationLinkAcuteClinical TrialsTechnologyProceduresUnited StatesCouplingDeath, Sudden, CardiacMyocardial IschemiaGap JunctionsMembrane Potentials

Grant awards (27)

Electrophysiology Scientific Core 2$262,430
P01 · FY2025 · HL · contact PI
Electrophysiology Scientific Core 2$257,183
P01 · FY2024 · HL · contact PI
Novel mechanisms and treatment of arrhythmia during resuscitation$636,193
R01 · FY2023 · HL · contact PI
Electrophysiology Scientific Core 2$262,430
P01 · FY2023 · HL · contact PI
Optically guided catheter ablation of atrial fibrillation$681,670
R01 · FY2022 · HL
Novel mechanisms and treatment of arrhythmia during resuscitation$636,193
R01 · FY2022 · HL · contact PI
Electrophysiology Scientific Core 2$262,430
P01 · FY2022 · HL · contact PI
Optically guided catheter ablation of atrial fibrillation$683,321
R01 · FY2021 · HL
Novel mechanisms and treatment of arrhythmia during resuscitation$660,343
R01 · FY2021 · HL · contact PI
Optically guided catheter ablation of atrial fibrillation$709,225
R01 · FY2020 · HL
Novel mechanisms and treatment of arrhythmia during resuscitation$668,976
R01 · FY2020 · HL · contact PI
Optically guided catheter ablation of atrial fibrillation$767,419
R01 · FY2019 · HL
Novel mechanisms and treatment of arrhythmia during resuscitation$602,854
R56 · FY2018 · HL · contact PI
Fully optical high throughput screening platform for drug induced arrhythmias$198,125
R21 · FY2016 · HL · contact PI
Fully optical high throughput screening platform for drug induced arrhythmias$237,750
R21 · FY2015 · HL · contact PI
A novel, multiparametric cardiac safety assay using human myocytes$192,000
R43 · FY2013 · HL · contact PI
A novel, multiparametric cardiac safety assay using human myocytes$12,976
R43 · FY2013 · HL · contact PI
Targeted cell therapy for the treatment of ventricular tachycardia$476,643
RC1 · FY2010 · HL · contact PI
Electrophysiological and antiarrhythmic benefit of cell therapy for heart disease$386,250
R01 · FY2010 · HL · contact PI
Targeted cell therapy for the treatment of ventricular tachycardia$495,951
RC1 · FY2009 · HL · contact PI
Electrophysiological and antiarrhythmic benefit of cell therapy for heart disease$386,250
R01 · FY2009 · HL · contact PI
Electrophysiological and antiarrhythmic benefit of cell therapy for heart disease$386,250
R01 · FY2008 · HL · contact PI
Electrophysiological and antiarrhythmic benefit of cell therapy for heart disease$386,250
R01 · FY2007 · HL · contact PI
Ca Handling &Arrhythmias Associated with LQT Syndrome$189,375
R01 · FY2005 · HL
Ca Handling &Arrhythmias Associated with LQT Syndrome$189,375
R01 · FY2004 · HL
Ca Handling &Arrhythmias Associated with LQT Syndrome$189,375
R01 · FY2003 · HL
Ca Handling &Arrhythmias Associated with LQT Syndrome$189,375
R01 · FY2002 · HL